2023 annual financial data

Compass Therapeutics 2023 Financial results

Compass Therapeutics 2023 financial results with verified reported values.

Direct answer

Revenue was 0 USD.

Operating income was -50,363,000 USD and net income was -42,494,000 USD.
Operating cash flow was -40,618,000 USD.

Get free Compass Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-50,363,000 USD
Net income
-42,494,000 USD
Operating cash flow
-40,618,000 USD